Evidence map›Paper›PMID 10323859›Full record

ArticleGenes & development1999

c-Myb is essential for early T cell development.

R D Allen, T P Bender, G Siu

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Transcriptional rewiring in CD8Frontiers in immunology · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

R D AllenDepartment of Microbiology, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.
T P Bender
G Siu
University of Virginia · USColumbia University · US

Funding

IMMUNOLOGICAL DISEASE MECHANISMST32AI007525 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GHOSH, SANKAR · 1997 to 2006
$2.3M
BIOLOGICAL ANALYSIS OF THE CD4 SILENCERR01AI034925 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SIU, GERALD J · 1996 to 2002
$966k
CONDITIONAL MUTATIONS AT THE C-MYB LOCUSF06TW002297 · FIC · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BENDER, TIMOTHY P. · 1998 to 1998
–
FIC NIH HHS F06 TW002297FIC NIH HHS TW02297NIAID NIH HHS AI34925NIAID NIH HHS R01 AI034925NIAID NIH HHS T32 AI007525NIGMS NIH HHS GM55985
6 · The paper itself

Abstract

The c-Myb transcription factor is important for fetal hematopoiesis and has been proposed to mediate later stages of lymphocyte development. Using homozygous null c-Myb/Rag1 chimeric mice, we have determined that c-Myb plays an important role in the differentiation of macrophages and lymphocytes from precursor stem cells. We also determine that deletion of c-Myb leads to a complete block in early T cell development just before the oligopotent thymocyte matures into the definitive T cell precursor. These data indicate that c-Myb plays an important role at multiple stages of hematopoiesis and is required at an early stage of T cell development.

Indexed as

OncogenesAnimalsCell DifferentiationGenes, RAG-1HematopoiesisHematopoietic Stem CellsHyaluronan ReceptorsMacrophagesMiceMice, KnockoutReceptors, Interleukin-2T-LymphocytesHyaluronan ReceptorsReceptors, Interleukin-2

Identifiers

PMID10323859
PMCPMC316940
OpenAlexW2099667634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.